Search details
1.
F-Box Protein-Mediated Resistance to PARP Inhibitor Therapy.
Mol Cell
; 73(2): 195-196, 2019 01 17.
Article
in English
| MEDLINE | ID: mdl-30658107
2.
Pharmacogenomics: Driving Personalized Medicine.
Pharmacol Rev
; 75(4): 789-814, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36927888
3.
Germline Variants Impact Somatic Events during Tumorigenesis.
Trends Genet
; 35(7): 515-526, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31128889
4.
Differences in somatic TP53 mutation type in breast tumors by race and receptor status.
Breast Cancer Res Treat
; 192(3): 639-648, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35286522
5.
Genetic analysis of a malignant meningioma and associated metastases.
Acta Neurochir (Wien)
; 164(5): 1401-1405, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34981192
6.
Machine learning approaches reveal subtle differences in breathing and sleep fragmentation in Phox2b-derived astrocytes ablated mice.
J Neurophysiol
; 125(4): 1164-1179, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-33502943
7.
Albert de la Chapelle (1933-2020).
Am J Hum Genet
; 108(2): 214-216, 2021 02 04.
Article
in English
| MEDLINE | ID: mdl-33545027
8.
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium.
J Med Genet
; 55(1): 15-20, 2018 01.
Article
in English
| MEDLINE | ID: mdl-28490613
9.
Polygenic risk scores for prostate cancer: testing considerations.
Can J Urol
; 26(5 Suppl 2): 17-18, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31629419
10.
Exploring genetic counselors' perceptions of usefulness and intentions to use refined risk models in clinical care based on the Technology Acceptance Model (TAM).
J Genet Couns
; 28(3): 664-672, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30843639
11.
DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment.
J Med Genet
; 54(11): 721-731, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28866612
12.
Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers.
J Genet Couns
; 27(5): 1291-1301, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29594659
13.
Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
Cancer
; 123(7): 1184-1193, 2017 04 01.
Article
in English
| MEDLINE | ID: mdl-27906449
14.
Outcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports.
J Genet Couns
; 26(5): 980-998, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28345121
15.
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Breast Cancer Res
; 18(1): 15, 2016 Feb 09.
Article
in English
| MEDLINE | ID: mdl-26857456
16.
Variants in an Hdac9 intronic enhancer plasmid impact Twist1 expression in vitro.
Mamm Genome
; 27(3-4): 99-110, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-26721262
17.
mrSNP: software to detect SNP effects on microRNA binding.
BMC Bioinformatics
; 15: 73, 2014 Mar 15.
Article
in English
| MEDLINE | ID: mdl-24629096
18.
Allele-specific imbalance mapping identifies HDAC9 as a candidate gene for cutaneous squamous cell carcinoma.
Int J Cancer
; 134(1): 244-8, 2014 Jan 01.
Article
in English
| MEDLINE | ID: mdl-23784969
19.
Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.
Mod Pathol
; 27(9): 1238-45, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-24457462
20.
Immunotherapy for colorectal cancer: insight from inherited genetics.
Trends Cancer
; 10(5): 444-456, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38360438